Gosset Ownership
Private
Therapeutic Areas
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Stealth NewCo General Information
Stealth NewCo is a South San Francisco-based biotech company founded in 2024 that specializes in discovering small molecule drugs for neurodegenerative diseases. The company employs advanced data analytics, biomarkers, high-throughput screening, and structure–activity relationship studies to identify promising therapeutic candidates. Its scientific team has deep experience in drug development. As of now, programs are preclinical with no disclosed clinical results or late-stage assets.
Contact Information
Primary Industry
Biotech
Corporate Office
South San Francisco, California
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
Stealth NewCo Funding
No funding data available
To view Stealth NewCo's complete valuation and funding history, request access »